Send me a link:

*Text messaging rates may apply.

 Dow Down0.28% Nasdaq Down0.17%

More On TKPYY

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Takeda Pharmaceutical Company Limited (TKPYY)

-Other OTC
23.17 Jul 21, 3:58PM EDT
|Pre-Market : NaN
ProfileGet Profile for:
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome
Chuo-Ku
Osaka, 540-8645
Japan - Map
Phone: 81 6 6204 2111
Fax: 81 6 6204 2880
Website: http://www.takeda.co.jp

Details 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:31,225

Business Summary 

Takeda Pharmaceutical Company Limited is engaged in supplying pharmaceutical products worldwide. The company provides products in various therapeutic areas, including cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, and gastrointestinal and genitourinary, as well as vaccines. It is also involved in the manufacture and sale of OTC drugs and quasi-drugs, reagents, clinical diagnostics, and chemical products. The company has strategic alliance with MacroGenics, Inc. to develop DART for treatment of autoimmune disorders. Takeda Pharmaceutical Company Limited was founded in 1781 and is based in Osaka, Japan.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Takeda Pharmaceutical Company Limited

Key Executives 
 PayExercised
Mr. Yasuchika Hasegawa , 68
Chairman and Chief Exec. Officer
N/AN/A
Mr. Christophe Weber ,
Pres, Chief Operating Officer and Representative Director
N/AN/A
Mr. Francois-Xavier Roger , 52
Chief Financial Officer, Sr. VP and Director
N/AN/A
Mr. Iwaaki Taniguchi ,
Sr. VP of Corp. Fin. & Controlling Department
N/AN/A
Dr. Tadataka Yamada M.D., 68
Chief Medical & Scientific Officer and Director
N/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.